Honduras vs Mauritania: Cause of death, by non-communicable diseases, female
Honduras
49.5%
in 2021
Mauritania
48.2%
in 2021
Honduras rank
143rd
Mauritania rank
146th
Cause of death, by non-communicable diseases, female over time
- Honduras
- Mauritania
How they compare
Honduras currently reports 49.5% against 48.2% in Mauritania, a difference of 1.3%.
Across all 6 years both countries report, Honduras has been ahead every year.
Honduras ranks 143rd and Mauritania ranks 146th of 185 countries.
Honduras has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Honduras | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 55.8% | 33.3% | 22.6% | Honduras |
| 2010s | 69.4% | 47.2% | 22.2% | Honduras |
| 2020s | 55.9% | 48.2% | 7.7% | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Honduras or Mauritania?
- Honduras, at 49.5% against 48.2% in Mauritania as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Honduras and Mauritania?
- 1.3%, with Honduras ahead.
- How many years of comparable data are there for Honduras and Mauritania?
- 6 years are reported by both, from 2000 to 2021.
- How do Honduras and Mauritania rank globally for cause of death, by non-communicable diseases, female?
- Honduras ranks 143rd and Mauritania ranks 146th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.